Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Is lansoprazole effective for the initial management of young patients with dyspepsia?

Mayer EA, Tillisch K.

Nat Clin Pract Gastroenterol Hepatol. 2008 Apr;5(4):200-1. doi: 10.1038/ncpgasthep1068. Epub 2008 Feb 19. No abstract available.

PMID:
18285815
2.

Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up.

Leung WK, Wu JC, Chan FK, Fung SS, Wong VW, Hui AJ, Hung LC, Sung JJ.

Am J Gastroenterol. 2007 Jul;102(7):1483-8.

PMID:
17593161
3.

Lansoprazole for long-term maintenance therapy of erosive esophagitis: double-blind comparison with ranitidine.

Peura DA, Freston JW, Haber MM, Kovacs TO, Hunt B, Atkinson S.

Dig Dis Sci. 2009 May;54(5):955-63. doi: 10.1007/s10620-008-0466-9. Epub 2008 Aug 23.

PMID:
18726153
4.

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.

Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K, Andersen LP, Wadström T.

Phytomedicine. 2008 Jun;15(6-7):391-9. doi: 10.1016/j.phymed.2008.04.004. Epub 2008 May 7.

PMID:
18467083
5.

Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.

van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, Van den Hazel S, Tan AC, Witteman BJ, Jansen JB.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):746-52; quiz 718. doi: 10.1016/j.cgh.2008.02.051. Epub 2008 Apr 18.

PMID:
18424191
6.

The impact of lifestyle modification on the health-related quality of life of patients with reflux esophagitis receiving treatment with a proton pump inhibitor.

Kinoshita Y, Ashida K, Miwa H, Hongo M.

Am J Gastroenterol. 2009 May;104(5):1106-11. doi: 10.1038/ajg.2009.77. Epub 2009 Mar 31.

PMID:
19337239
7.

Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.

Kushner PR, Snoddy AM, Gilderman L, Peura DA.

Postgrad Med. 2009 Jul;121(4):67-75. doi: 10.3810/pgm.2009.07.2019.

PMID:
19641272
8.

Current guidelines for dyspepsia management.

Ford AC, Moayyedi P.

Dig Dis. 2008;26(3):225-30. doi: 10.1159/000121351. Epub 2008 May 6. Review.

PMID:
18463440
9.

Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.

Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M.

Am J Gastroenterol. 2008 Aug;103(8):1906-19. doi: 10.1111/j.1572-0241.2008.01953.x. Epub 2008 Jul 4.

10.

Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.

Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M.

J Pediatr. 2009 Apr;154(4):514-520.e4. doi: 10.1016/j.jpeds.2008.09.054. Epub 2008 Dec 3.

PMID:
19054529
11.

The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study.

Hongo M, Kinoshita Y, Miwa H, Ashida K.

J Gastroenterol. 2008;43(12):920-7. doi: 10.1007/s00535-008-2257-7. Epub 2008 Dec 24.

PMID:
19107335
12.

Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux.

Khoshoo V, Dhume P.

J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):352-4. doi: 10.1097/MPG.0b013e31815667d7.

PMID:
18376260
13.

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.

Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, Ashida K, Fukuchi T, Hojo M, Yamashita H, Tomita T, Hori K, Oshima T.

Am J Gastroenterol. 2009 Nov;104(11):2779-87. doi: 10.1038/ajg.2009.427. Epub 2009 Jul 28.

PMID:
19638966
14.

A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.

Tack J, Masclee A, Heading R, Berstad A, Piessevaux H, Popiela T, Vandenberghe A, Kato H.

Neurogastroenterol Motil. 2009 Mar;21(3):272-80. doi: 10.1111/j.1365-2982.2009.01261.x.

PMID:
19254354
15.

Lansoprazole for children with poorly controlled asthma.

Bossley C.

Arch Dis Child Educ Pract Ed. 2013 Oct;98(5):199. doi: 10.1136/archdischild-2013-304692. Epub 2013 Aug 21. No abstract available.

PMID:
23966207
16.

Children, asthma, and proton pump inhibitors: costs and perils of therapeutic creep.

Martinez FD.

JAMA. 2012 Jan 25;307(4):406-7. doi: 10.1001/jama.2012.33. No abstract available.

PMID:
22274689
17.

The effect of Helicobacter pylori eradication on dyspeptic symptoms, acid reflux and quality of life in patients with functional dyspepsia.

Bektas M, Soykan I, Altan M, Alkan M, Ozden A.

Eur J Intern Med. 2009 Jul;20(4):419-23. doi: 10.1016/j.ejim.2008.11.007. Epub 2008 Dec 30.

PMID:
19524187
18.

[Treatment of colon dyspepsia with Vi-Siblin].

Becker U, Bjerrum L, Pilgaard S, Paerregaard A, Olsson MS.

Ugeskr Laeger. 1980 Feb 25;142(9):570-2. Danish. No abstract available.

PMID:
6247801
19.

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication.

Eisig JN, Silva FM, Barbuti RC, Rodriguez TN, Malfertheiner P, Moraes Filho JP, Zaterka S.

BMC Gastroenterol. 2009 May 26;9:38. doi: 10.1186/1471-230X-9-38.

20.

Proton pump inhibitors for dyspepsia.

Vakil N.

Dig Dis. 2008;26(3):215-7. doi: 10.1159/000121349. Epub 2008 May 6. Review.

PMID:
18463438

Supplemental Content

Support Center